Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer

NCT05502237 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1021

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Zimberelimab
DRUG: Domvanalimab
DRUG: Pembrolizumab
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Paclitaxel
DRUG: Nab-paclitaxel
DRUG: Pemetrexed

Sponsor

Gilead Sciences

Collaborators

[object Object]